Please enable Javascript
Jordi Rodón Ahnert, MD, PhD
Articles by Jordi Rodón Ahnert, MD, PhD
Sacituzumab Tirumotecan for Gastric Cancer With TROP2 expression: The KL264-01 Trial
Jordi Rodón Ahnert, MD, PhD
Gastric Cancer
|
March 13, 2025
Dr. Rodón Ahnert compares the differences of sacituzumab tirumotecan use in the second- vs third-line setting for patients.
View More